🇺🇸 FDA
Pipeline program

TachoSil®

TC-2402-038-SP

Phase 3 other completed

Quick answer

TachoSil® for Cerebrospinal Fluid Leaks is a Phase 3 program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Cerebrospinal Fluid Leaks
Phase
Phase 3
Modality
other
Status
completed

Clinical trials